What does CUSIP 38341P102 represent in this 13F holders report?

CUSIP 38341P102 is the security identifier for GOSS - Gossamer Bio, Inc. - Common Stock, $0.0001 par value used to aggregate holder disclosures.

How many institutions held GOSS - Gossamer Bio, Inc. - Common Stock, $0.0001 par value in Q2 2021?

109 institutional investors reported GOSS - Gossamer Bio, Inc. - Common Stock, $0.0001 par value for Q2 2021. Use the holders table for investor-level position and value details.

Gossamer Bio, Inc. - Common Stock, $0.0001 par value (GOSS)

CUSIP: 38341P102

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class: Equity / Common Stock, $0.0001 par value
Shares outstanding: 236,211,947
Total 13F shares: 53,088,201
Share change: -1,156,924
Total reported value: $431,075,177
Put/Call ratio: 822%
Price per share: $8.12
Number of holders: 109
Value change: -$10,198,257
Number of buys: 44
Number of sells: 58

Quarterly Holders Quick Answers

What is CUSIP 38341P102?
CUSIP 38341P102 identifies GOSS - Gossamer Bio, Inc. - Common Stock, $0.0001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2021
Previous quarter: Q1 2021

Recent filing periods for CUSIP 38341P102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of GOSS - Gossamer Bio, Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
HHLR ADVISORS, LTD.	13F	Company	3.1%	7,420,974	$68,644,000	—	31 Mar 2021	13F
VANGUARD GROUP INC	13F	Company	2.3%	5,381,751	$49,781,000	—	31 Mar 2021	13F
BlackRock Finance, Inc.	13F	Company	2.3%	5,365,349	$49,630,000	—	31 Mar 2021	13F
STATE STREET CORP	13F	Company	1.6%	3,865,681	$35,758,000	—	31 Mar 2021	13F
FEDERATED HERMES, INC.	13F	Company	1.5%	3,462,200	$32,025,000	—	31 Mar 2021	13F
Omega Fund Management, LLC	13F	Company	1.4%	3,320,608	$30,716,000	—	31 Mar 2021	13F
Boxer Capital, LLC	13F	Company	1.1%	2,562,358	$23,702,000	—	31 Mar 2021	13F
Artal Group S.A.	13F	Company	1%	2,358,968	$21,820,000	—	31 Mar 2021	13F
Palo Alto Investors LP	13F	Company	0.75%	1,772,950	$16,400,000	—	31 Mar 2021	13F
Octagon Capital Advisors LP	13F	Company	0.6%	1,413,138	$13,072,000	—	31 Mar 2021	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.45%	1,060,554	$9,810,000	—	31 Mar 2021	13F
Ikarian Capital, LLC	13F	Company	0.44%	1,048,383	$9,697,000	—	31 Mar 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.41%	977,097	$9,038,000	—	31 Mar 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.4%	944,294	$8,735,000	—	31 Mar 2021	13F
Cormorant Asset Management, LP	13F	Company	0.36%	848,382	$7,848,000	—	31 Mar 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.36%	845,594	$7,821,000	—	31 Mar 2021	13F
Marshall Wace North America L.P.	13F	Company	0.36%	840,642	$7,776,000	—	31 Mar 2021	13F
NORGES BANK	13F	Company	0.31%	724,800	$6,704,000	—	31 Mar 2021	13F
Alyeska Investment Group, L.P.	13F	Company	0.3%	720,066	$6,661,000	—	31 Mar 2021	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.3%	698,075	$6,457,000	—	31 Mar 2021	13F
NORTHERN TRUST CORP	13F	Company	0.26%	603,140	$5,579,000	—	31 Mar 2021	13F
Parkman Healthcare Partners LLC	13F	Company	0.25%	582,890	$5,392,000	—	31 Mar 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.25%	580,796	$5,372,000	—	31 Mar 2021	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.21%	490,200	$4,534,000	—	31 Mar 2021	13F
CLOUGH CAPITAL PARTNERS L P	13F	Company	0.19%	458,634	$4,242,000	—	31 Mar 2021	13F
EMERALD ADVISERS, LLC	13F	Company	0.19%	451,430	$4,176,000	—	31 Mar 2021	13F
EMERALD MUTUAL FUND ADVISERS TRUST	13F	Company	0.19%	448,352	$4,147,000	—	31 Mar 2021	13F
MORGAN STANLEY	13F	Company	0.14%	328,960	$3,043,000	—	31 Mar 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.14%	320,000	$2,960,000	—	31 Mar 2021	13F
Sio Capital Management, LLC	13F	Company	0.11%	261,400	$2,418,000	—	31 Mar 2021	13F
Bank of New York Mellon Corp	13F	Company	0.1%	234,275	$2,167,000	—	31 Mar 2021	13F
CITIGROUP INC	13F	Company	0.09%	217,633	$2,013,000	—	31 Mar 2021	13F
Hudson Bay Capital Management LP	13F	Company	0.07%	175,000	$1,619,000	—	31 Mar 2021	13F
Rafferty Asset Management, LLC	13F	Company	0.07%	173,628	$1,606,000	—	31 Mar 2021	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.06%	150,000	$1,388,000	—	31 Mar 2021	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.06%	145,607	$1,347,000	—	31 Mar 2021	13F
Ensign Peak Advisors, Inc	13F	Company	0.06%	145,076	$1,342,000	—	31 Mar 2021	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.06%	143,456	$1,327,000	—	31 Mar 2021	13F
ALPS ADVISORS INC	13F	Company	0.06%	137,371	$1,271,000	—	31 Mar 2021	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.06%	136,622	$1,264,000	—	31 Mar 2021	13F
DOWLING & YAHNKE LLC	13F	Company	0.05%	125,575	$1,162,000	—	31 Mar 2021	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.05%	115,200	$1,066,000	—	31 Mar 2021	13F
PDT Partners, LLC	13F	Company	0.05%	112,820	$1,044,000	—	31 Mar 2021	13F
Swiss National Bank	13F	Company	0.05%	111,400	$1,030,000	—	31 Mar 2021	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.04%	100,455	$929,000	—	31 Mar 2021	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	0.04%	100,254	$927,000	—	31 Mar 2021	13F
Russell Investments Group, Ltd.	13F	Company	0.04%	87,624	$809,000	—	31 Mar 2021	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.04%	85,439	$790,000	—	31 Mar 2021	13F
UBS Group AG	13F	Company	0.03%	80,986	$749,000	—	31 Mar 2021	13F
RHUMBLINE ADVISERS	13F	Company	0.03%	78,268	$724,000	—	31 Mar 2021	13F

Institutional Holders of Gossamer Bio, Inc. - Common Stock, $0.0001 par value (GOSS) as of Q2 2021

As of 30 Jun 2021, Gossamer Bio, Inc. - Common Stock, $0.0001 par value (GOSS) was held by 109 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 53,088,201 shares. The largest 10 holders included HHLR ADVISORS, LTD., VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, Omega Fund Management, LLC, FEDERATED HERMES, INC., BOXER CAPITAL, LLC, Artal Group S.A., Palo Alto Investors LP, and Octagon Capital Advisors LP. This page lists 109 institutional shareholders reporting positions in this security for the Q2 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2021 vs Q1 2021 Across Filers

Q1 2021 holders

121

Q2 2021 holders

109

Holder diff

-12

Investor	Q1 2021 Shares	Q2 2021 Shares	Share Diff	Share Chg %	Q1 2021 Value $	Q2 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.